Interview: Improving accuracy of lung cancer screening
Interview: Improving accuracy of lung cancer screenin ...
Encouraging findings in NTRK-, ROS1– and ALK-positive lung cancer
Encouraging findings in NTRK-, ROS1– and ALK-positive ...
Immunotherapy: analyses elucidating durvalumab & pembrolizumab activity
Immunotherapy: analyses elucidating durvalumab & ...
Current perspectives in EGFR-targeted therapy
Current perspectives in EGFR-targeted therapy Glo ...
Preface – ELCC 2019
Preface – ELCC 2019 Pilar Garrido, MD, PhD Head o ...